 <h1>Kuvan Side Effects</h1><p class="drug-subtitle"><b>Generic Name:</b> <i>sapropterin</i></p><ul class="ddc-anchor-links"><li>Consumer</li>
<li>Professional</li></ul><p class="ddc-notification"><b>Note:</b> This document contains side effect information about sapropterin. Some of the dosage forms listed on this page <em>may not</em> apply to the brand name Kuvan.</p><h2>In Summary</h2><p><b>Common side effects of Kuvan include:</b> headache and rhinorrhea.  See below for a comprehensive list of adverse effects.</p><h2 class="ddc-anchor-offset" id="consumer">For the Consumer</h2><p><i>Applies to sapropterin: oral powder for solution, oral tablet disintegrating</i></p><h3>Side effects requiring immediate medical attention</h3><p>Along with its needed effects, sapropterin (the active ingredient contained in Kuvan) may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.</p><p>
<b>Check with your doctor immediately</b> if any of the following side effects occur while taking sapropterin:</p><p>
<i>More common</i>
</p><ul>
<li>Fever</li>
</ul><p>
<i>Incidence not known</i>
</p><ul>
<li>Burning feeling in the chest or stomach</li>
<li>cough</li>
<li>difficulty with swallowing</li>
<li>dizziness</li>
<li>fast heartbeat</li>
<li>fidgeting or moving around too much</li>
<li>heartburn</li>
<li>indigestion</li>
<li>pain or burning in the throat</li>
<li>puffiness or swelling of the eyelids or around the eyes, face, lips, or tongue</li>
<li>skin rash, hives, or itching</li>
<li>sores, ulcers, or white spots on lips or tongue or inside the mouth</li>
<li>stomach upset</li>
<li>talking too much</li>
<li>tenderness in the stomach area</li>
<li>tightness in the chest</li>
<li>trouble swallowing</li>
<li>unusual tiredness or weakness</li>
</ul><h3>Side effects not requiring immediate medical attention</h3><p>Some side effects of sapropterin may occur that usually <b>do not need medical attention</b>. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.</p><p>Check with your health care professional if any of the following side effects <b>continue or are bothersome</b> or if you have any questions about them:</p><p>
<i>More common</i>
</p><ul>
<li>Diarrhea</li>
<li>headache</li>
<li>runny nose</li>
<li>sore throat</li>
<li>vomiting</li>
</ul><p>
<i>Less common</i>
</p><ul>
<li>Stuffy nose</li>
</ul><p>
<!-- end oral powder for solution, oral tablet disintegrating --><div class="related-links"><svg aria-hidden="true" class="ddc-icon ddc-icon-info" focusable="false" height="22" viewbox="0 0 24 24" width="22" xmlns="http://www.w3.org/2000/svg"><path d="M14 2H6c-1.1 0-1.99.9-1.99 2L4 20c0 1.1.89 2 1.99 2H18c1.1 0 2-.9 2-2V8l-6-6zm2 16H8v-2h8v2zm0-4H8v-2h8v2zm-3-5V3.5L18.5 9H13z"></path></svg> <span>Managing side effects <span class="ddc-text-nowrap">(general information)</span></span></div>
<h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to sapropterin: oral powder for reconstitution, oral tablet soluble</i></p><h3>General</h3><p>The more commonly reported adverse effects include headache, rhinorrhea, pharyngolaryngeal pain, diarrhea, vomiting, cough, and nasal congestion.<sup>[Ref]</sup></p><h3>Nervous system</h3><p>Two cases of hyperactivity have been received during the postmarketing period; in 1 case, the patient had inadvertently received an overdose of this drug.<sup>[Ref]</sup></p><p><b>Very common</b> (10% or more): Headache (15%)</p>
<p><b>Common</b> (1% to 10%): Dizziness</p>
<p><b>Frequency not reported</b>: Convulsions, exacerbation of convulsions, overstimulation</p>
<p><b>Postmarketing reports</b>: Hyperactivity<sup>[Ref]</sup></p><h3>Respiratory</h3><p><b>Very common</b> (10% or more): Rhinorrhea (11%), pharyngolaryngeal pain (10%)</p>
<p><b>Common</b> (1% to 10%): Cough, nasal congestion, pharyngitis, upper respiratory tract infection</p>
<p><b>Frequency not reported</b>: Respiratory failure</p>
<p><b>Postmarketing reports</b>: Pharyngitis<sup>[Ref]</sup></p><h3>Metabolic</h3><p>Not all patients respond to therapy; in clinical trials, 25% to 44% of pediatric phenylketonuria (PKU) patients receiving 20 mg/kg/day did not respond to therapy and 80% of adult and pediatric PKU patients receiving 10 mg/kg/day did not respond to therapy.<sup>[Ref]</sup></p><p><b>Very common</b> (10% or more): Low phenylalanine levels, non-response to therapy</p>
<p><b>Common</b> (1% to 10%): Hypophenylalaninemia<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p><b>Common</b> (1% to 10%): Diarrhea, vomiting, nausea, abdominal pain, upper abdominal pain</p>
<p><b>Frequency not reported</b>: Gastrointestinal bleeding, esophageal stricture, esophageal ulcer, gastric ulcer, bleeding </p>
<p><b>Postmarketing reports</b>: Oropharyngeal pain, esophageal pain, gastritis, dyspepsia, abdominal pain, nausea, vomiting<sup>[Ref]</sup></p><h3>Cardiovascular</h3><p><b>Frequency not reported</b>: Myocardial infarction<sup>[Ref]</sup></p><h3>Other</h3><p><b>Common</b> (1% to 10%): Peripheral edema</p>
<p><b>Frequency not reported</b>: Contusion, postprocedural bleeding, pyrexia<sup>[Ref]</sup></p><h3>Psychiatric</h3><p><b>Common</b> (1% to 10%): Agitation</p>
<p><b>Frequency not reported</b>: Irritability</p><h3>Musculoskeletal</h3><p><b>Common</b> (1% to 10%): Arthralgia<sup>[Ref]</sup></p><h3>Genitourinary</h3><p><b>Common</b> (1% to 10%): Polyuria<sup>[Ref]</sup></p><h3>Hypersensitivity</h3><p><b>Postmarketing reports</b>: Hypersensitivity reactions (including serious allergic reactions, anaphylaxis, rash)<sup>[Ref]</sup></p><h3>Dermatologic</h3><p><b>Frequency not reported</b>: Rash<sup>[Ref]</sup></p><h3>Hepatic</h3><p><b>Frequency not reported</b>: Increased GGT<sup>[Ref]</sup></p><div class="referenceList"><h4 id="refs">References</h4><p id="ref_1">1. "Product Information. Kuvan (sapropterin)." BioMarin Pharmaceutical Inc, Novato, CA. </p><p id="ref_2">2. Dubois EA,  Cohen AF "Sapropterin." Br J Clin Pharmacol 69 (2010): 576-7</p><p id="ref_3">3. Cerner Multum,  Inc. "Australian Product Information." O 0</p><p id="ref_4">4. Cerner Multum,  Inc. "UK Summary of Product Characteristics." O 0</p></div>
<div class="more-resources" id="moreResources">
<h2>More about Kuvan (sapropterin)</h2>
<ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy or 
Breastfeeding</li>
<li>Dosage Information</li>
<li>Drug Images</li>
<li>Drug Interactions</li>
<li>Compare Alternatives</li>
<li>Pricing &amp; Coupons</li>
<li>En Espa√±ol</li>
<li>Generic Availability</li>
<li>Drug class: miscellaneous metabolic agents</li>
<li>FDA Approval History</li>
</ul>
<h3>Consumer resources</h3>
<ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
<li>Kuvan &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
</ul>
<h3>Professional resources</h3>
<ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li data-more-config-id="list-data-resources-professional">... +1 more</li>
</ul>
<h3>Related treatment guides</h3>
<ul class="more-resources-list more-resources-list-conditions">
<li>Phenylketonuria</li>
</ul>
</div>
<h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p>
<p>Some side effects may not be reported. You may report them to the FDA.</p>
<p class="ddc-disclaimer-link">Medical Disclaimer</p>
<script>
function showRefs(refs) {
	if (!document.querySelectorAll) {
		return;
	}

	var referenceIds = refs ? refs.split(',') : [];
	var referenceTitle = referenceIds.length
		 ? "References relevant to chosen section <span class='ddc-text-size-small font-weight-normal'>(<a href='#refs' onclick='showRefs(\"\"); return false;'>Show all references</a>)</span>"
		 : "References";
	document.getElementById('refs').innerHTML = referenceTitle;

	// Show/hide reference items
	var referenceList = document.querySelectorAll('.referenceList p');
	referenceList.forEach(function(item) {
		var id = item.id.replace('ref_', '');
		if (!referenceIds.length || referenceIds.includes(id)) {
			item.style.display = 'block';
		}
		else {
			item.style.display = 'none';
		}
	});
}
</script>
</p><h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to sapropterin: oral powder for reconstitution, oral tablet soluble</i></p><h3>General</h3><p>The more commonly reported adverse effects include headache, rhinorrhea, pharyngolaryngeal pain, diarrhea, vomiting, cough, and nasal congestion.<sup>[Ref]</sup></p><h3>Nervous system</h3><p>Two cases of hyperactivity have been received during the postmarketing period; in 1 case, the patient had inadvertently received an overdose of this drug.<sup>[Ref]</sup></p><p><b>Very common</b> (10% or more): Headache (15%)</p><p><b>Common</b> (1% to 10%): Dizziness</p><p><b>Frequency not reported</b>: Convulsions, exacerbation of convulsions, overstimulation</p><p><b>Postmarketing reports</b>: Hyperactivity<sup>[Ref]</sup></p><h3>Respiratory</h3><p><b>Very common</b> (10% or more): Rhinorrhea (11%), pharyngolaryngeal pain (10%)</p><p><b>Common</b> (1% to 10%): Cough, nasal congestion, pharyngitis, upper respiratory tract infection</p><p><b>Frequency not reported</b>: Respiratory failure</p><p><b>Postmarketing reports</b>: Pharyngitis<sup>[Ref]</sup></p><h3>Metabolic</h3><p>Not all patients respond to therapy; in clinical trials, 25% to 44% of pediatric phenylketonuria (PKU) patients receiving 20 mg/kg/day did not respond to therapy and 80% of adult and pediatric PKU patients receiving 10 mg/kg/day did not respond to therapy.<sup>[Ref]</sup></p><p><b>Very common</b> (10% or more): Low phenylalanine levels, non-response to therapy</p><p><b>Common</b> (1% to 10%): Hypophenylalaninemia<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p><b>Common</b> (1% to 10%): Diarrhea, vomiting, nausea, abdominal pain, upper abdominal pain</p><p><b>Frequency not reported</b>: Gastrointestinal bleeding, esophageal stricture, esophageal ulcer, gastric ulcer, bleeding </p><p><b>Postmarketing reports</b>: Oropharyngeal pain, esophageal pain, gastritis, dyspepsia, abdominal pain, nausea, vomiting<sup>[Ref]</sup></p><h3>Cardiovascular</h3><p><b>Frequency not reported</b>: Myocardial infarction<sup>[Ref]</sup></p><h3>Other</h3><p><b>Common</b> (1% to 10%): Peripheral edema</p><p><b>Frequency not reported</b>: Contusion, postprocedural bleeding, pyrexia<sup>[Ref]</sup></p><h3>Psychiatric</h3><p><b>Common</b> (1% to 10%): Agitation</p><p><b>Frequency not reported</b>: Irritability</p><h3>Musculoskeletal</h3><p><b>Common</b> (1% to 10%): Arthralgia<sup>[Ref]</sup></p><h3>Genitourinary</h3><p><b>Common</b> (1% to 10%): Polyuria<sup>[Ref]</sup></p><h3>Hypersensitivity</h3><p><b>Postmarketing reports</b>: Hypersensitivity reactions (including serious allergic reactions, anaphylaxis, rash)<sup>[Ref]</sup></p><h3>Dermatologic</h3><p><b>Frequency not reported</b>: Rash<sup>[Ref]</sup></p><h3>Hepatic</h3><p><b>Frequency not reported</b>: Increased GGT<sup>[Ref]</sup></p><p id="ref_1">1. "Product Information. Kuvan (sapropterin)." BioMarin Pharmaceutical Inc, Novato, CA. </p><p id="ref_2">2. Dubois EA,  Cohen AF "Sapropterin." Br J Clin Pharmacol 69 (2010): 576-7</p><p id="ref_3">3. Cerner Multum,  Inc. "Australian Product Information." O 0</p><p id="ref_4">4. Cerner Multum,  Inc. "UK Summary of Product Characteristics." O 0</p><h2>More about Kuvan (sapropterin)</h2><ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy or 
Breastfeeding</li>
<li>Dosage Information</li>
<li>Drug Images</li>
<li>Drug Interactions</li>
<li>Compare Alternatives</li>
<li>Pricing &amp; Coupons</li>
<li>En Espa√±ol</li>
<li>Generic Availability</li>
<li>Drug class: miscellaneous metabolic agents</li>
<li>FDA Approval History</li>
</ul><h3>Consumer resources</h3><ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
<li>Kuvan &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
</ul><h3>Professional resources</h3><ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li data-more-config-id="list-data-resources-professional">... +1 more</li>
</ul><h3>Related treatment guides</h3><ul class="more-resources-list more-resources-list-conditions">
<li>Phenylketonuria</li>
</ul><h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p><p>Some side effects may not be reported. You may report them to the FDA.</p><p class="ddc-disclaimer-link">Medical Disclaimer</p>